GURU.Markets stock price, segment price, and overall market index valuation
The company's share price A
Agilent Technologies produces high-precision laboratory equipment and software. Its customers include pharmaceutical companies, chemists, and scientists. The company's share price growth reflects the continued demand for innovation in science and quality control, from drug development to product safety testing.
Share prices of companies in the market segment - Medanalysis
Agilent, spun off from Hewlett-Packard, is a leading manufacturer of analytical equipment and laboratory instruments. We classify it as part of the Medanalysis sector, and the chart below reflects the dynamics of this segment, driven by R&D spending in the pharmaceutical and scientific industries.
Broad Market Index - GURU.Markets
Agilent Technologies is a leader in analytical and diagnostic equipment, supplying instruments and software to laboratories worldwide. It is a key component of the GURU.Markets index. The chart below represents the market. See how investments in life sciences impact Agilent's business.
Change in the price of a company, segment, and market as a whole per day
A - Daily change in the company's share price A
Agilent is a leading provider of analytical instruments, software, and laboratory services. Its daily price change is a measure of volatility in the life sciences sector. This metric, while not spectacular, is an important element in the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
Agilent Technologies, Inc. is a leading supplier of laboratory equipment. This chart shows the average daily volatility of the life sciences sector. Comparing it with the dynamics of A helps understand how resilient its business, which relies on R&D spending, is to economic cycles.
Daily change in the price of a broad market stock, index - GURU.Markets
Agilent Technologies is a leading provider of analytical equipment and software for laboratories. Its business serves as a barometer of activity in global science and biotechnology. The chart below shows general market fluctuations, which can be used to assess the stability of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization A
Agilent is a leading manufacturer of analytical laboratory equipment. Its year-over-year performance reflects the level of global R&D investment in the pharmaceutical, chemical, and food industries. The chart below tells the story of its indispensable role in the world of science.
Annual dynamics of market capitalization of the market segment - Medanalysis
Agilent Technologies, Inc. is a leading provider of laboratory instruments, software, and services. Its products are used in pharmaceuticals, biotechnology, and chemical analysis. The chart shows how its innovation and strong position in the life sciences market enable it to achieve consistent growth that outpaces the industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Agilent Technologies is a leading provider of laboratory instruments and software for the life sciences and chemical industries. Demand for its products is stable, driven by R&D spending. This makes Agilent resilient to economic cycles and allows it to demonstrate strong growth.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization A
Agilent Technologies' (A) Perf_Month_Co market capitalization reflects medium-term investment cycles in the pharmaceutical, chemical, and research sectors for its measurement equipment. Monthly fluctuations in the chart are driven by laboratory equipment purchase volumes and demand for its services.
Monthly dynamics of market capitalization of the market segment - Medanalysis
This chart shows the dynamics of the life sciences sector. For Agilent, a leading analytical instrument maker, this provides context. Its movements reflect R&D spending by pharmaceutical and biotech companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Agilent Technologies, Inc. is a leader in analytical and diagnostic laboratory instruments. Its customers are from stable industries such as pharmaceuticals, food, and environmental monitoring. The broader market graph shows how consistent demand for its high-tech equipment has made its business resilient to general economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization A
Shares of Agilent Technologies, a manufacturer of analytical laboratory equipment, reflect weekly investments in scientific research. Price movements reflect the spending of pharmaceutical, chemical, and food companies on quality control and new product development.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Laboratory equipment manufacturing is a sector that serves as a barometer for scientific research. The weekly performance of the entire industry depends on R&D spending in the pharmaceutical and chemical industries. The chart illustrates this overall backdrop, which allows one to appreciate the breadth of Agilent's product line.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Agilent Technologies is a leading provider of analytical equipment and software for laboratories. Its customers span the pharmaceutical, chemical, and food industries. The chart below shows how insulated Agilent shares are from overall market volatility thanks to stable demand from science-intensive industries.
Market capitalization of the company, segment and market as a whole
A - Market capitalization of the company A
Agilent's market capitalization chart tells the story of creating high-precision measurement instruments for laboratories in science, medicine, and industry. Its steady growth since its spinoff from HP reflects the continued demand for analytical instruments. Its growth reflects the market's assessment of its leadership in areas such as genomics, diagnostics, and quality control.
A - Share of the company's market capitalization A within the market segment - Medanalysis
Agilent Technologies is a leading provider of analytical instruments, software, and laboratory services. Spinning off from Hewlett-Packard, the company has achieved a leading share of the life sciences, diagnostics, and chemical markets. The chart shows the importance of this technology leader, whose equipment is the foundation of many scientific discoveries.
Market capitalization of the market segment - Medanalysis
Agilent Technologies is a leading provider of analytical equipment, software, and laboratory services. The chart below shows the overall market capitalization of this knowledge-intensive sector. Its steady growth reflects the ongoing need for accurate analysis in the pharmaceutical, food, and scientific research industries.
Market capitalization of all companies included in a broad market index - GURU.Markets
Agilent Technologies is a leader in analytical equipment and laboratory software. Its market capitalization reflects the importance of precise measurements in science and industry, from pharmaceuticals to environmental protection. Agilent's growth chart reflects the pulse of scientific research and quality control.
Book value capitalization of the company, segment and market as a whole
A - Book value capitalization of the company A
Agilent Technologies' balance sheet consists of its factories producing high-precision analytical equipment for laboratories, as well as its R&D centers and patent portfolio. This is real, knowledge-intensive capital that enables scientists to make new discoveries. How has this technological foundation grown? The chart below shows the dynamics of its stable development.
A - Share of the company's book capitalization A within the market segment - Medanalysis
Agilent Technologies manufactures high-precision analytical equipment for laboratories at its own facilities. The chart shows the share of these manufacturing assets in the sector, reflecting the physical scale behind the instruments that make scientific discoveries possible.
Market segment balance sheet capitalization - Medanalysis
Manufacturing analytical equipment like Agilent's is capital-intensive. Compared to its healthcare assets, the need to own high-tech factories and R&D centers makes the company a technological heavyweight.
Book value of all companies included in the broad market index - GURU.Markets
Agilent Technologies' assets are factories producing high-precision analytical laboratory equipment used in pharmaceuticals, biotechnology, and environmental monitoring. Its book value reflects the company's production and technological potential as it creates tools for scientific discovery. The chart shows its importance in this knowledge-intensive industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - A
Agilent, a manufacturer of high-precision laboratory equipment, is valued at a premium to its manufacturing plants. Investors are paying for its strong brand, its reputation for quality, and its indispensable role in industries such as pharmaceuticals, biotechnology, and food safety.
Market to book capitalization ratio in a market segment - Medanalysis
Agilent Technologies is a leader in analytical instrumentation and laboratory software. Its customers include pharmaceutical, chemical, and food companies. The chart shows how the market values ββits reputation, instrument accuracy, and stable demand from science-intensive industries.
Market to book capitalization ratio for the market as a whole
Agilent Technologies is a leading supplier of analytical instruments, software, and laboratory consumables. The company operates in the pharmaceutical, diagnostic, and chemical analysis markets. This metric reflects the premium the market places on its technological leadership and stable consumables revenue in evergreen industries.
Debts of the company, segment and market as a whole
A - Company debts A
Agilent Technologies, a manufacturer of analytical equipment and laboratory software, uses its stable cash flow to fund innovation and targeted acquisitions. Debt is used sparingly to maintain financial flexibility. This chart illustrates a balanced growth strategy in the high-tech niche.
Market segment debts - Medanalysis
Agilent Technologies is a leading manufacturer of analytical equipment and software for laboratories in the life sciences, chemical, and food industries. The company was spun out of Hewlett-Packard. This chart shows how Agilent uses its capital to fund R&D and niche acquisitions to remain at the forefront of scientific measurement.
Market debt in general
Agilent Technologies is a leader in analytical instrumentation, software, and laboratory services. The company serves the life sciences, diagnostics, and chemical markets. This chart provides an overview of how Agilent funds its research and development and the sustainability of its debt policy in a stable yet competitive market.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio A
Agilent Technologies supplies high-tech equipment for laboratories where innovation is key. This chart shows how the company funds its research and development. It reflects the balance between debt and equity, allowing one to assess how aggressively Agilent invests in maintaining its technological leadership and expanding into new markets.
Market segment debt to market segment book capitalization - Medanalysis
Agilent Technologies, a leading provider of analytical instruments, software, and laboratory services. This chart compares the company's debt to the overall market capitalization of the entire sector. It helps understand how the company, spun off from Hewlett-Packard, finances its research and development in the pharmaceutical, biotechnology, and chemical analysis markets.
Debt to book value of all companies in the market
Agilent, a laboratory equipment supplier, operates in the defensive healthcare and science sector. This chart compares the company's debt to the overall market capitalization. It helps understand how the company's financial policy, supported by stable demand for research, is unaffected by short-term economic downturns.
P/E of the company, segment and market as a whole
P/E - A
Agilent Technologies is a leading provider of analytical instruments, software, and laboratory consumables. This chart shows how investors value its key role in the pharmaceutical, chemical, and food industries. The consistently high valuation reflects the continued demand for precise measurements and quality control.
P/E of the market segment - Medanalysis
Agilent Technologies is a leader in the life sciences, diagnostics, and applied chemistry markets. The company provides laboratories worldwide with instruments, services, consumables, and software. This chart shows the average score for the medical analysis sector, helping to assess Agilent's technological leadership.
P/E of the market as a whole
Agilent Technologies, spun off from Hewlett-Packard, is a leader in laboratory analytical equipment. Its customers are in the pharmaceutical, chemical, and food industries. To what extent does its valuation depend on R&D budgets in these industries, and to what extent does it follow general market trends, as reflected in this chart?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company A
Agilent Technologies produces analytical instruments, software, and laboratory consumables. The company's future profitability depends on R&D spending in the pharmaceutical, chemical, and food industries. This chart shows market expectations for increased investment in research and quality control.
Future (projected) P/E of the market segment - Medanalysis
Agilent Technologies produces analytical instruments, software, and laboratory consumables for the life sciences, diagnostics, and chemical industries. This chart shows how the market views Agilent's profitability prospects, reflecting expectations of robust demand from pharmaceutical companies, biotech companies, and research institutes.
Future (projected) P/E of the market as a whole
Agilent Technologies produces analytical instruments, software, and laboratory consumables. Their customers are in the pharmaceutical, biotechnology, and chemical industries. This general expectations chart shows that demand for high-precision measurements and research remains stable, supporting Agilent's growth.
Profit of the company, segment and market as a whole
Company profit A
Agilent Technologies produces analytical instruments, software, and laboratory consumables. This chart shows how the company makes money from science. Profit growth depends on R&D spending in the pharmaceutical, chemical, and food industries, which ensures stable demand for its equipment.
Profit of companies in the market segment - Medanalysis
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment across a variety of industries, from pharmaceuticals to environmental science. This chart shows profitability in the medical analysis sector. Agilent's high-precision equipment is the standard in many research studies, ensuring the company's stable demand and customer loyalty.
Overall market profit
Agilent Technologies produces analytical instruments, software, and laboratory consumables across various industries, including pharmaceuticals, chemicals, and food. Demand for its products depends on R&D budgets and quality control. This chart, which shows the health of the corporate sector, is an indicator for Agilent of its customers' willingness to invest.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company A
Agilent Technologies is a leading provider of laboratory instruments, software, and services. This chart shows analysts' expectations for future profits. The forecast is driven by research and development spending in the pharmaceutical, chemical, and food industries, where Agilent equipment is the standard for analysis and quality control.
Future (predicted) profit of companies in the market segment - Medanalysis
Agilent Technologies is a leading provider of analytical equipment, software, and services for laboratories worldwide. The sector revenue projections shown in the graph highlight the company's investment in research and development and quality control. This chart helps assess the diversification of Agilent's business across end markets, such as pharmaceuticals and environmental services.
Future (predicted) profit of the market as a whole
Agilent Technologies produces analytical instruments, software, and laboratory consumables. Its customers operate in the pharmaceutical, chemical, and food safety industries. Demand for its products is driven by research and quality control spending, which is growing in a stable and growing economy, as reflected in this chart.
P/S of the company, segment and market as a whole
P/S - A
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment. The company's revenue is diversified across the pharmaceutical, chemical, and food markets. This chart shows how investors value their robust sales. Their high valuation reflects their key role in scientific research and quality control.
P/S market segment - Medanalysis
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment. The company's products are used in pharmaceutical, biotechnology, and chemical analysis to ensure quality and safety. This chart shows the average rating for the sector, helping to understand how the market values ββAgilent's technological leadership and reputation.
P/S of the market as a whole
Agilent Technologies is a leader in analytical equipment, software, and laboratory consumables. The company's products are used in the pharmaceutical, chemical analysis, and food industries. This chart provides an overview of how the market perceives the revenue of this high-tech company serving scientific markets.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company A
Agilent Technologies is a leader in analytical instrumentation, software, and laboratory consumables. This chart shows how investors estimate its future revenue. This valuation is fueled by stable demand from the pharmaceutical, chemical, and food industries.
Future (projected) P/S of the market segment - Medanalysis
Agilent Technologies provides instruments, software, and consumables for laboratories worldwide. This chart compares the company's estimated future sales with other analytical equipment manufacturers. It reflects investor expectations for stable demand for its products from pharmaceutical, chemical, and research organizations.
Future (projected) P/S of the market as a whole
Agilent Technologies produces analytical equipment, software, and laboratory consumables in various industries, from pharmaceuticals to environmental protection. Demand for its products depends on research and development (R&D) spending. This graph of overall growth expectations is important for Agilent, as economic growth stimulates companies' investments in R&D and quality control.
Sales of the company, segment and market as a whole
Company sales A
This is the revenue chart for Agilent Technologies, a manufacturer of analytical equipment and laboratory software. Its instruments are used in the pharmaceutical, biotechnology, chemical analysis, and food industries. Revenue growth reflects increased investment in research and development, as well as stricter product quality and safety requirements across various industries.
Sales of companies in the market segment - Medanalysis
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment. Its instruments are used in the pharmaceutical, chemical analysis, and food industries for quality control and research. This chart shows revenue in the medical analysis sector. It reflects rising R&D spending and stricter quality standards, which drives continued demand for Agilent's high-precision instruments.
Overall market sales
Agilent Technologies produces analytical instruments, software, and laboratory consumables. Its customers operate in the pharmaceutical, chemical analysis, and food industries. Demand for its products depends on R&D and quality control expenditures. This graph of overall economic activity is an indicator of investment in science and manufacturing, which drives Agilent's sales.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company A
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment. This revenue forecast chart reflects research and development spending in knowledge-intensive industries. This increase is driven by expectations of increased demand from pharmaceutical, chemical, and food companies for its high-precision measuring instruments.
Future (projected) sales of companies in the market segment - Medanalysis
Agilent Technologies produces high-tech analytical and laboratory equipment, software, and consumables. Their instruments are used in pharmaceuticals, chemical analysis, and diagnostics. This chart shows projected revenues for the entire medical analysis sector, reflecting the level of investment in research and quality control across various industries.
Future (projected) sales of the market as a whole
Agilent Technologies produces analytical instruments, software, and laboratory consumables. Its customers operate in the pharmaceutical, biotechnology, and chemical industries. Growth forecasts in these knowledge-intensive industries, which are driven by overall investment trends, directly impact demand for Agilent's high-precision equipment.
Marginality of the company, segment and market as a whole
Company marginality A
Agilent Technologies produces analytical instruments, software, and laboratory consumables. This chart demonstrates the stability of its business, serving markets such as pharmaceuticals, biotechnology, and chemical analysis. The company's ongoing need for testing and research ensures steady demand and high profitability.
Market segment marginality - Medanalysis
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment. The company provides instruments, consumables, and software for various industries. Its success depends on the profitability of its high-tech solutions. This chart shows the average profitability in the sector, allowing you to assess the strength of Agilent's innovation and market position.
Market marginality as a whole
Agilent Technologies is a leader in providing laboratory instruments and solutions in the life sciences, diagnostics, and chemistry industries. Demand for its products is driven not so much by the general economic cycles shown in this chart as by R&D spending in the pharmaceutical industry and quality control standards in industry.
Employees in the company, segment and market as a whole
Number of employees in the company A
Agilent Technologies, spun off from Hewlett-Packard's instrumentation division, is a leading supplier of analytical laboratory equipment. Its instruments are used in everything from pharmaceuticals to environmental monitoring. This chart shows the team of scientists and engineers who create the tools for scientific discovery.
Share of the company's employees A within the market segment - Medanalysis
Agilent Technologies is a leader in the life sciences and diagnostics markets, providing analytical instruments. Its innovation is driven by a large research team, and its global reach is driven by a robust sales and service organization. This chart reflects its scale as a key laboratory technology provider, demonstrating its share of the scientific instrument industry workforce.
Number of employees in the market segment - Medanalysis
Agilent Technologies is a leading manufacturer of analytical equipment and software for laboratories in the pharmaceutical, biotechnology, and chemical industries. This chart illustrates the growth of knowledge-intensive industries. The constant demand for more accurate and faster research and quality control instruments ensures the company's stable growth and demand for qualified personnel.
Number of employees in the market as a whole
Agilent Technologies provides high-tech laboratory equipment. Its qualified staff of scientists and engineers reflects its investment in scientific analysis and discoveries in pharmaceuticals, food safety, and other industries.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company A (A)
Agilent Technologies produces high-tech laboratory measurement equipment. Their value lies in the precision of their instruments and their strong brand. This chart is high for them, reflecting the knowledge-intensive nature of their business. Each of their engineers contributes to the creation of complex devices that set the standard in the pharmaceutical and chemical industries.
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Agilent Technologies is a manufacturer of high-precision laboratory equipment and analytical software. It is an R&D-intensive business serving the pharmaceutical, chemical, and scientific industries. This metric, compared to the industry average, reflects how much the market values ββtheir engineering, patents, and brand per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
Agilent Technologies produces analytical equipment and software for laboratories. This indicator reflects the value of precision and innovation in science. The company creates instruments essential for research in pharmaceuticals, chemistry, and biotechnology. Its high profit margins and reputation ensure its team's contributions are highly valued.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company A (A)
Agilent Technologies is a leader in analytical and laboratory equipment, spun off from HP. They serve the biotech, chemical, and medical industries. It's a high-tech business. This chart shows the value of their R&D. Their high profit per employee is a result of selling complex, expensive instruments and consumables.
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Agilent is a leader in laboratory equipment (life sciences, diagnostics). This chart shows the benchmark for Med-Analysis. The average profit per employee is high here. This is the "razor and blade business." The benchmark reflects stable, high-margin revenue from "blades" (disposable consumables, software), generated by a small staff.
Profit per employee (in thousands of dollars) for the market as a whole
Agilent Technologies is a leader in analytical and diagnostic laboratory equipment. The company's instruments are used in science, healthcare, and quality control. This chart shows how effectively this manufacturer of complex scientific equipment monetizes the intellectual labor of its engineers and scientists.
Sales to employees of the company, segment and market as a whole
Sales per company employee A (A)
Agilent Technologies produces analytical equipment and software for laboratories. This chart demonstrates the value of their high-tech products. Their high revenue per employee reflects the demand for precision measuring instruments in the pharmaceutical, chemical, and scientific research industries.
Sales per employee in the market segment - Medanalysis
Agilent Technologies is a leading supplier of laboratory equipment (chromatographs, spectrometers) and software for the pharmaceutical, chemical, and scientific industries. It is an R&D-intensive business with a "razor and blades" model (equipment and consumables). This chart shows the average revenue per employee in the sector. It helps assess the productivity of Agilent's R&D and S&M teams.
Sales per employee for the market as a whole
Agilent Technologies is a leading manufacturer of analytical and diagnostic laboratory equipment. Their instruments are used in the pharmaceutical, chemical, and food industries. It is an engineering business with a "razor-sharp" model (instruments and consumables). This metric reflects how their R&D creates high-margin products.
Short shares by company, segment and market as a whole
Shares shorted by company A (A)
Agilent Technologies produces high-tech analytical equipment (spectrometers, chromatographs) for laboratories in the pharmaceutical, chemical, and food industries. This chart shows bearish bets. Bears can expect cuts in R&D budgets in biotech and pharmaceuticals due to funding problems in the industry.
Shares shorted by market segment - Medanalysis
Agilent Technologies is a manufacturer of high-precision measurement and analytical equipment (chromatographs, spectrometers) for laboratories, primarily in the pharmaceutical, chemical, and biotech industries. This figure reflects skepticism. Shorting Agilent is a bet on a slowdown in R&D. Investors fear that biotech and pharmaceutical companies will cut their research budgets, which will reduce demand for Agilent's expensive lab equipment.
Shares shorted by the overall market
Agilent Technologies produces high-tech analytical instruments (spectrometers, chromatographs) for laboratories. Its customers are in the pharmaceutical, chemical, and biotechnology industries. This indicator of market fear signals possible cuts in corporate R&D budgets. During periods of pessimism, companies may postpone the purchase of expensive new equipment, which will impact Agilent's orders.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator A (A)
Agilent Technologies produces analytical equipment for laboratories (pharmaceuticals, chemicals). The business depends on R&D budgets. A reading above 70 may reflect strong demand from the biotech sector. A reading below 30 may signal concerns about R&D budget cuts due to economic difficulties.
RSI 14 Market Segment - Medanalysis
Agilent (A) is a "shovel supplier" for laboratories. They produce analytical instruments (chromatographs, spectrometers) for the pharmaceutical, chemical, and biotech industries. This metric measures the "temperature" of the sector. It helps understand: is A "oversold" due to a decline in R&D budgets in biotech or is there a general "cooling" in the entire sector?
RSI 14 for the overall market
Agilent Technologies produces analytical equipment and software for laboratories in the life sciences, diagnostics, and chemistry. It is a high-tech supplier to the scientific community. This chart measures overall investor sentiment. It helps understand whether fluctuations in A are caused by general panic in the medtech sector (oversold) or euphoria, rather than actual R&D budgets at pharmaceutical companies.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast A (A)
Agilent Technologies is a leading provider of analytical instruments, software, and laboratory consumables. Their equipment is used in the pharmaceutical, chemical, and biotech industries. This chart is a collective 12-month forecast from analysts. It reflects their expectations for R&D budgets among Agilent's customers, particularly in the life sciences sector.
The difference between the consensus estimate and the actual stock price A (A)
Agilent (A) is a leading manufacturer of analytical equipment and laboratory software. Their instruments are used in the pharmaceutical, chemical, and diagnostic industries. This chart shows the life sciences market valuation. It illustrates the gap between the price and the consensus target, reflecting the potential analysts see in the stable demand for high-precision measurement equipment.
Analyst consensus forecast for stock prices by market segment - Medanalysis
Agilent is a leading manufacturer of analytical equipment (spectrometers, chromatographs) for laboratories. Their instruments are used in the pharmaceutical, chemical, and food industries. This chart shows analysts' overall expectations for the "scientific instruments" sector. It reflects whether experts believe R&D budgets will grow globally.
Analysts' consensus forecast for the overall market share price
Agilent Technologies provides analytical instruments, software, and services for laboratories in the life sciences, diagnostics, and chemical analysis sectors. This chart reflects overall market sentiment. For Agilent, whose business relies on R&D spending in the pharmaceutical and industrial sectors, the overall analyst optimism is important, as it signals companies' willingness to invest in new laboratory equipment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index A
Agilent Technologies (spinned off from HP) is a leading supplier of analytical instruments, software, and laboratory consumables. Their customers are in the pharmaceutical, chemical, and food industries. This chart is an indicator of R&D and quality control spending. It reflects the stable demand for high-precision measurement equipment from their key defense markets (pharma and biotech).
AKIMA Market Segment Index - Medanalysis
Agilent Technologies is a leading supplier of laboratory equipment and consumables (spinned off from HP), serving the life sciences, diagnostics, and chemical analysis markets. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does Agilent's indispensable role in scientific research differentiate it from the average competitor?
The AKIM Index for the overall market
Agilent Technologies, a spinoff from HP, is a leading provider of analytical equipment and software for laboratories in the pharmaceutical, chemical, and environmental sectors. This chart, which reflects the market average, provides context. It helps assess how Agilent, whose business relies on R&D budgets in defense sectors, compares to the overall macroeconomic environment, which influences investor sentiment and capital expenditures.